You are here: Industry Insights > Covaxin

News List

Ocugen intends to sell 100 million doses of COVAXIN in US in 2021 expresspharma
March 17, 2021
Ocugen plans to sell 100 million doses of India’s Covaxin in the US this year, Shankar Musunuri, CEO of the company told Reuters.
Covaxin granted restricted EUA expresspharma
March 12, 2021
Bharat Biotech’s indigenously developed Covaxin is out of the “clinical trial mode” and it has now been granted the restricted emergency use authorisation.
India’s Covaxin® 81 percent effective against COVID-19 europeanpharmaceuticalreview
March 09, 2021
An interim analysis reveals the Covaxin® (BBV152) vaccine was relatively safe and 81 percent effective in preventing symptomatic COVID-19.
Bharat Biotech’s Covid-19 vaccine shows interim efficacy of 81% pharmaceutical-technology
March 05, 2021
Indian firm Bharat Biotech has reported that the first interim analysis of Phase III study of its whole virion inactivated Covid-19 vaccine candidate, COVAXIN (BBV152), demonstrated clinical efficacy of 81%.
Bharat Biotech announces Phase III results of COVAXIN expresspharma
March 04, 2021
The trials involved 25,800 subjects, in partnership with the Indian Council of Medical Research.
WHO chief scientist says India exhibited capacity to innovate, manufacture vaccines expresspharma
March 03, 2021
India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization’s Chief Scientist Soumya Swaminathan said Monday.
Liability for COVID vaccines in India: Where does the buck stop? expresspharma
March 02, 2021
A month into Indias country-wide vaccination drive that began in January 2021, and we have reportedly seen the death of 27 people already, including that of a 24-year-old medical intern, a mere 11 days after her vaccination.
Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN expresspharma
March 01, 2021
Bharat Biotech International confirmed that the company has signed an agreement with Brazil for supply of 20 million doses of COVAXIN.
Ukraine delegation visit Bharat Biotech’s vaccine facility, discuss supplies of COVAXIN to Ukraine expresspharma
February 25, 2021
Led by Dr Maksym Stepanov, Minister of Health, Ukraine, the delegation also included Igor Ivashchenko, Deputy Minister of Health, Ukraine, and Ivan Konovalov, Head of Trade and Economic Dept, Embassy of Ukraine in India.
Bharat Biotech seeks approval for COVID-19 vaccine in over 40 countries expresspharma
February 20, 2021
Pricing of COVAXIN for international markets will be based upon supply timelines, purchase commitments and procurement volumes, informed the company.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page